The optimal therapy for locally advanced, unresectable, stage III non–small-cell lung cancer (NSCLC) continues to evolve. The critical determinants of overall survival include local tumor control and the
Gary S. Gordon, MD
Advertisement
Articles by Gary S. Gordon, MD
Advertisement
Latest Updated Articles
- Chemoradiation for Locally Advanced, Unresectable NSCLC
August 1st 1999
Advertisement
Advertisement
Trending on CancerNetwork
1
Data Readouts to Watch at the 2026 ASCO Annual Meeting
2
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
3
Navigating The Dynamic Landscape of Stem Cell Transplantation
4
Outlining Exercise as a “Biologically Interventional Therapy” for Cancer
5